Advertisement

Marihuana pp 415-424 | Cite as

Cannabinoids and the Inhibition of Prostaglandin Synthesis

  • J. F. Howes
  • P. F. Osgood
Conference paper

Abstract

During the last decade, there has been a rapid expansion of interest in both prostaglandins and cannabinoids. Prostaglandins are being recognized as basic to many physiological or pathological functions, and it is not surprising that many drugs interact with them. Evidence is accumulating that Δ9-tetrahydrocannabinol (Δ9-THC) and other cannabinoidlike agents affect prostaglandin synthesis. For this to be a viable hypothesis, it is necessary to indicate clear physiological changes caused by Δ9-THC that are attributable to inhibition of prostaglandin synthesis.

Keywords

Arachidonic Acid Luteinizing Hormone Intraocular Pressure Prostaglandin Synthesis Luteinizing Hormone Secretion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Abdulla, Y. H. and E. McFarlane (1972) Control of prostaglandin biosynthesis in rat brain homogenates by adenine nucleotides. Biochem. Pharmacol. 21: 2841.PubMedCrossRefGoogle Scholar
  2. 2.
    Bergstrom, S., L. Farnebo and K. Fuxe (1973) Effect of prostaglandin E2 on central and peripheral catecholamine neurons. Eur. J. Pharmacol. 21: 562.CrossRefGoogle Scholar
  3. 3.
    Burstein, S., E. Levin and C. Varanelli (1973) Prostaglandins and cannabis II: inhibition of biosynthesis by the naturally occurring cannabinoids. Biochem. Pharmacol. 22: 2905.PubMedCrossRefGoogle Scholar
  4. 4.
    Burstein, S. and A. Raz (1972) Inhibition of prostaglandin E2 synthesis by Δ1-tetrahydrocannabinol. Prostaglandins 2: 569.CrossRefGoogle Scholar
  5. 5.
    Chiang, T. S. and R. P. Thomas (1972) Effects of progesterone and epinephrine on the ocular hypertensive response to intravenous infusion of prostaglandin E1. 5th International Congress on Pharmacology, abstract No. 243.Google Scholar
  6. 6.
    Crowshaw, K. and H. F. Hardman (1974) Effect of Δ9-tetrahydro-cannabinol (Δ9-THC) on prostaglandin (PG) synthesis and the relationship of this effect to the hypothermic response in mice. Fed. Proc. 33: abstract No. 1847.Google Scholar
  7. 7.
    Fereira, S. H. and S. Moncada (1971) Inhibition of prostaglandin synthesis augments the effects of sympathetic nerve stimulation on the cat spleen. Br. J. Pharmacol. 43:419P.Google Scholar
  8. 8.
    Frank, I. M., R. S. Hepler, L. Epps, J. T. Ungerleider and S. Szara (1972) Marihuana and delta-9-tetrahydrocannabinol: effects on intraocular pressure in young adults. 5th International Congress on Pharmacology, abstract No. 426.Google Scholar
  9. 9.
    Green, K. and S. M. Podos (1974) Antagonism of arachidonic acid-induced ocular effects by Δ1-tetrahydrocannabinol. Invest. Ophthalmol. 13: 422, 1974.PubMedGoogle Scholar
  10. 10.
    Hedqvist, P., L. Stjarne, and A. Wennmalm (1971) Facilitation of sympathetic neurotransmission in the cat spleen after inhibition of prostaglandin synthesis. Acta Physiol. Scand. 83: 430.PubMedCrossRefGoogle Scholar
  11. 11.
    Hepler, R. S. and I. M. Frank (1971) Letter to the editor, marihuana smoking and intraocular pressure. J.A.M.A. 217: 1392.PubMedCrossRefGoogle Scholar
  12. 12.
    Holmes, S. W. and E. W. Horton (1967) Prostaglandins and the central nervous system. Prostaglandin Symposium of the Worcester Foundation for Experimental Biology (P. W. Ramwell and S. E. Shaw, eds.). New York: Interscience Publishers, pp. 21–38.Google Scholar
  13. 13.
    Howes, J. F. (1973) The effect of Δ9-tetrahydrocannabinoid on amphetamine induced lethality in aggregated mice. Res. Commun. Chem. Pathol. Pharmacol. 6: 895.PubMedGoogle Scholar
  14. 14.
    Howes, J. F. and P. F. Osgood (1974) The effect of Δ9-tetrahydro-cannabinol on the uptake and release of 14C-dopamine from crude striatal synaptosomal preparations. Neuropharmacology 13: 1109.PubMedCrossRefGoogle Scholar
  15. 15.
    Howes, J. F. and P. F. Osgood (1974) The effects of Δ9-THC and a water soluble derivative on PGE1 synthesis on the corpus striatum. Pharmacologist 16: abstract 389.Google Scholar
  16. 16.
    Kadowitz, P. J., P. D. Joinir, and A. L. Hyman (1975) Physiological and pharmacological roles of prostaglandins. Annu. Rev. Pharmacol. 15: 285.PubMedCrossRefGoogle Scholar
  17. 17.
    Kosersky, D. S., W. L. Dewey, and L. S. Harris (1973) Antipyretic, analgesic and anti-inflammatory effects of Δ9-tetrahydrocannabinol in the rat. Eur. J. Pharmacol. 24: 1.PubMedCrossRefGoogle Scholar
  18. 18.
    McAfee, D. A. and P. Greengard (1972) Adenosine 3′5′-monophosphate: electrophysiological evidence for a role in synaptic transmission. Science. 178: 310.PubMedCrossRefGoogle Scholar
  19. 19.
    McGiff, J. C (1975) Prostaglandins as regulators of blood pressure. Hosp. Prac. 101.Google Scholar
  20. 20.
    Nakano, J, A. C. K. Chang, and R. G. Fisher (1972) Effect of prostaglandins E2 and F2a on the carotid arterial blood flow, cerebrospinal fluid pressure and intraocular pressure in dogs. Proc. Soc. Exp. Biol. Med. 140: 866.PubMedGoogle Scholar
  21. 21.
    Osgood, P. F. and J. F. Howes (1974) Cannabinoid induced changes in mouse striatal homovanillic acid and dehydroxyphenylacetic acid. The effects of amphetamine and l-dopa. Res. Commun. Chem. Pathol. Pharmacol. 9: 621.PubMedGoogle Scholar
  22. 22.
    Samuelsson, B. and A. Wennmalm (1971) Increased nerve stimulation induced release of noradrenaline from the rabbit heart after inhibition of prostaglandin synthesis. Acta Physiol. Scand. 83: 163.PubMedCrossRefGoogle Scholar
  23. 23.
    Sofia, R. D., L. C. Knoblock, and H. B. Varsar (1973) The anti-edema activity of various naturally occurring cannabinoids. Res. Commun. Chem. Pathol. Pharmacol. 6: 909.PubMedGoogle Scholar
  24. 24.
    Sofia, R. D., S. D. Nalepa, J. J. Harakal and H. B. Varsar (1973) Anti-edema and analgesic properties of Δ9-tetrahydrocannabinol (THC). J. Pharmacol. Exp. Ther. 186: 646.PubMedGoogle Scholar
  25. 25.
    Sofia, R. D., S. D. Nalepa, H. B. Varsar, and L. C. Knoblock (1974) Comparative antiphilogistic activity of Δ9-tetrahydrocannabinol, hydrocortisone and aspirin in various rat paw edema models. Life Sci. 15: 251.PubMedCrossRefGoogle Scholar
  26. 26.
    Sofia, R. D., T. A. Solomon, and M. Barry, III (1971) The anticonvulsant activity of Δ1-tetrahydrocannabinol in mice. Pharmacologist 13: Abstract 309.Google Scholar
  27. 27.
    Turkanis, S., W. Cely, D. M. Olsen, and R. Karler (1974) Anticonvulsant properties of cannabidiol. Res. Commun. Chem. Pathol. Pharmacol. 8: 231.PubMedGoogle Scholar
  28. 28.
    Vachon, L., M. X. Fitzgerald, N. H. Solliday, I. A. Gould and E. A. Gaensler (1973) Single dose effect of marihuana smoke. Bronchial dynamics and respiratory center sensitivity in normal subjects. N. Engl. J. Med. 288: 985.PubMedCrossRefGoogle Scholar
  29. 29.
    Walker, J. B. and J. P. Walker (1973) Neurohumoral regulation of adenylate cyclase activity in the rat striatum. Brain Res. 54: 386.PubMedCrossRefGoogle Scholar
  30. 30.
    Zimmerman, B. G., M. J. Ryan, S. Gomer, and E. Kraft (1973) Effect of the prostaglandin synthesis inhibitors indomethacin and eicosa-5, 8, 11, 14-tetraenoic acid on adrenergic responses in dog cutaneous vasculature. J. Pharmacol. Exp. Ther. 187: 315, 1973.PubMedGoogle Scholar
  31. 31.
    Zitko, B. A., J. F. Howes, R. K. Razdan, B. C. Dalzell, H. C. Dalzell, J. C. Sheehan, H. G. Pars, W. L. Dewey and L. S. Harris (1972) Water soluble derivatives of Δ1-tetrahydrocannabinol. Science 177: 442.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag New York Inc. 1976

Authors and Affiliations

  • J. F. Howes
  • P. F. Osgood

There are no affiliations available

Personalised recommendations